Diabetes, Vol 46, Issue 8 1354-1359, Copyright © 1997 by American Diabetes Association

ARTICLES

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM

S Lehto, T Ronnemaa, SM Haffner, K Pyorala, V Kallio and M Laakso
Department of Medicine, Kuopio University Hospital, Finland.

Patients with NIDDM are at increased risk for coronary heart disease (CHD). However, information on the predictive value of cardiovascular risk factors and the degree of hyperglycemia with respect to the risk for CHD in diabetic patients is still limited. Therefore, we carried out a prospective study on risk factors for CHD, including a large number of NIDDM patients. At baseline, risk factor levels of CHD were determined in 1,059 NIDDM patients (581 men and 478 women), aged from 45 to 64 years. These patients were followed up to 7 years with respect to CHD events. Altogether, 158 NIDDM patients (97 men [16.7%] and 61 women [12.8%]) died of CHD and 256 NIDDM patients (156 men [26.8%] and 100 women [20.9%]) had a serious CHD event (death from CHD or nonfatal myocardial infarction). A previous history of myocardial infarction, low HDL cholesterol level (<1.0 mmol/l), high non-HDL cholesterol (> or =5.2 mmol/l), high total triglyceride level (>2.3 mmol/l), and high fasting plasma glucose (>13.4 mmol/l) were associated with a twofold increase in the risk of CHD mortality or morbidity, independently of other cardiovascular risk factors. High calculated LDL cholesterol level (> or =4.1 mmol/l) was significantly associated with all CHD events. The simultaneous presence of high fasting glucose (>13.4 mmol/l) with low HDL cholesterol, low HDL-to-total cholesterol ratio, or high total triglycerides further increased the risk for CHD events up to threefold. Our 7-year follow-up study provides evidence that dyslipidemia and poor glycemic control predict CHD mortality and morbidity in patients with NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K.-L. Chien, H.-C. Hsu, T.-C. Su, M.-F. Chen, Y.-T. Lee, and F. B. Hu Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese J. Lipid Res., November 1, 2007; 48(11): 2499 - 2505. [Abstract] [Full Text] [PDF]

				A. Shankar, R. Klein, B. E. K. Klein, and S. E. Moss Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 Diabetes Am. J. Epidemiol., August 15, 2007; 166(4): 393 - 402. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]

				M. Rodriguez-Lee, G. Ostergren-Lunden, B. Wallin, J. Moses, G. Bondjers, and G. Camejo Fatty Acids Cause Alterations of Human Arterial Smooth Muscle Cell Proteoglycans That Increase the Affinity for Low-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 130 - 135. [Abstract] [Full Text] [PDF]

				R. de Vries, F. G. Perton, G. M. Dallinga-Thie, A. M. van Roon, B. H.R. Wolffenbuttel, A. van Tol, and R. P.F. Dullaart Plasma Cholesteryl Ester Transfer Is a Determinant of Intima-Media Thickness in Type 2 Diabetic and Nondiabetic Subjects: Role of CETP and Triglycerides Diabetes, December 1, 2005; 54(12): 3554 - 3559. [Abstract] [Full Text] [PDF]

				J. Liu, C. Sempos, R. P. Donahue, J. Dorn, M. Trevisan, and S. M. Grundy Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes Diabetes Care, August 1, 2005; 28(8): 1916 - 1921. [Abstract] [Full Text] [PDF]

				A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk Diabetes Care, December 1, 2004; 27(12): 2898 - 2904. [Abstract] [Full Text] [PDF]

				E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. L. Brancati, N. R. Powe, and S. H. Golden Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus Ann Intern Med, September 21, 2004; 141(6): 421 - 431. [Abstract] [Full Text] [PDF]

				L. D. Monti, C. Landoni, E. Setola, E. Galluccio, P. Lucotti, E. P. Sandoli, A. Origgi, G. Lucignani, P. Piatti, and F. Fazio Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1225 - H1231. [Abstract] [Full Text] [PDF]

				R. Jiang, M. B. Schulze, T. Li, N. Rifai, M. J. Stampfer, E. B. Rimm, and F. B. Hu Non-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes Diabetes Care, August 1, 2004; 27(8): 1991 - 1997. [Abstract] [Full Text] [PDF]

				C. Lajoie, A. Calderone, F. Trudeau, N. Lavoie, G. Massicotte, S. Gagnon, and L. Beliveau Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats J Appl Physiol, May 1, 2004; 96(5): 1606 - 1612. [Abstract] [Full Text] [PDF]

				M. Rewers, D. Zaccaro, R. D'Agostino, S. Haffner, M. F. Saad, J. V. Selby, R. Bergman, and P. Savage Insulin Sensitivity, Insulinemia, and Coronary Artery Disease: The Insulin Resistance Atherosclerosis Study Diabetes Care, March 1, 2004; 27(3): 781 - 787. [Abstract] [Full Text] [PDF]

				L. Djousse, D. K Arnett, H. Coon, M. A Province, L. L Moore, and R C. Ellison Fruit and vegetable consumption and LDL cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study Am. J. Clinical Nutrition, February 1, 2004; 79(2): 213 - 217. [Abstract] [Full Text] [PDF]

				I. Pavo, G. Jermendy, T. T. Varkonyi, Z. Kerenyi, A. Gyimesi, S. Shoustov, M. Shestakova, M. Herz, D. Johns, B. J. Schluchter, et al. Effect of Pioglitazone Compared with Metformin on Glycemic Control and Indicators of Insulin Sensitivity in Recently Diagnosed Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1637 - 1645. [Abstract] [Full Text] [PDF]

				S. Fenkci, V. Fenkci, M. Yilmazer, M. Serteser, and T. Koken Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension Hum. Reprod., April 1, 2003; 18(4): 866 - 870. [Abstract] [Full Text] [PDF]

				S. Vijan and R. A. Hayward Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med, April 1, 2003; 138(7): 593 - 602. [Abstract] [Full Text] [PDF]

				N. Mitsuhashi, T. Onuma, and R. Kawamori Response to Ostberg and Hurel Diabetes Care, March 1, 2003; 26(3): 961 - 962. [Full Text] [PDF]

				W. Lu, H. E. Resnick, K. A. Jablonski, K. L. Jones, A. K. Jain, Wm. J. Howard, D. C. Robbins, and B. V. Howard Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study Diabetes Care, January 1, 2003; 26(1): 16 - 23. [Abstract] [Full Text] [PDF]

				S. H. Hsia Non-HDL Cholesterol: Into the Spotlight Diabetes Care, January 1, 2003; 26(1): 240 - 242. [Full Text] [PDF]

				V. Bittner, R. Hardison, S. F. Kelsey, B. H. Weiner, A. K. Jacobs, and G. Sopko Non-High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) Circulation, November 12, 2002; 106(20): 2537 - 2542. [Abstract] [Full Text] [PDF]

				S. M. Haffner and R. B. Goldberg New Strategies for the Treatment of Diabetic Dyslipidemia Diabetes Care, July 1, 2002; 25(7): 1237 - 1239. [Full Text] [PDF]

				D. E. Kelley, G. A. Bray, F. X. Pi-Sunyer, S. Klein, J. Hill, J. Miles, and P. Hollander Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes: A 1-year randomized controlled trial Diabetes Care, June 1, 2002; 25(6): 1033 - 1041. [Abstract] [Full Text] [PDF]

				J. V. Selby, A. J. Karter, L. M. Ackerson, A. Ferrara, and J. Liu Developing a Prediction Rule From Automated Clinical Databases to Identify High-Risk Patients in a Large Population With Diabetes Diabetes Care, September 1, 2001; 24(9): 1547 - 1555. [Abstract] [Full Text] [PDF]

				U. Olsson, A.-C. Egnell, M. R. Lee, G. O. Lunden, M. Lorentzon, M. Salmivirta, G. Bondjers, and G. Camejo Changes in Matrix Proteoglycans Induced by Insulin and Fatty Acids in Hepatic Cells May Contribute to Dyslipidemia of Insulin Resistance Diabetes, September 1, 2001; 50(9): 2126 - 2132. [Abstract] [Full Text] [PDF]

				Y. Cui, R. S. Blumenthal, J. A. Flaws, M. K. Whiteman, P. Langenberg, P. S. Bachorik, and T. L. Bush Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality Arch Intern Med, June 11, 2001; 161(11): 1413 - 1419. [Abstract] [Full Text] [PDF]

				A. I Adler, I. M Stratton, H A. W Neil, J. S Yudkin, D. R Matthews, C. A Cull, A. D Wright, R. C Turner, and R. R Holman Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ, August 12, 2000; 321(7258): 412 - 419. [Abstract] [Full Text]

				T. Hammoud, J.-F. Tanguay, and M. G. Bourassa Management of coronary artery disease: therapeutic options in patients with diabetes J. Am. Coll. Cardiol., August 1, 2000; 36(2): 355 - 365. [Abstract] [Full Text] [PDF]

				I. Saito, A. R. Folsom, F. L. Brancati, B. B. Duncan, L. E. Chambless, and P. G. McGovern Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Ann Intern Med, July 18, 2000; 133(2): 81 - 91. [Abstract] [Full Text] [PDF]

				J. L. Dixon, J. D. Stoops, J. L. Parker, M. H. Laughlin, G. A. Weisman, and M. Sturek Dyslipidemia and Vascular Dysfunction in Diabetic Pigs Fed an Atherogenic Diet Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2981 - 2992. [Abstract] [Full Text] [PDF]

				R. A. DeFronzo Pharmacologic Therapy for Type 2 Diabetes Mellitus Ann Intern Med, August 17, 1999; 131(4): 281 - 303. [Abstract] [Full Text] [PDF]

				S. M. Haffner The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease Endocr. Rev., October 1, 1998; 19(5): 583 - 592. [Abstract] [Full Text]

				S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction N. Engl. J. Med., July 23, 1998; 339(4): 229 - 234. [Abstract] [Full Text] [PDF]